Upcoming Webinars Archived Webinars Training Vitals Host A Webinar About Get Updates Contact
October 10, 2006 1:00pm – 3:00pm EDT
RFID for Pharma
- Peggy Staver, Director of Trade Product Integrity, Pfizer Learn More
- Gurdave Ahluwalia, Global Biopharma Program Manager, Intel Learn More

- Tim Chandler, RFID Strategy Manager, Intel
Learn More
Archive Options
Full Archive Audio Only
 Podcast Options
iTunes Podcast SubscribeAll Podcast OptionsXtalks!Listen Now! To all archive in the PodcastXtalks!

Exploring the First Stage Implementation Results of Pfizer’s RFID Pilot Program

Counterfeit drugs are a major concern for pharmaceutical manufacturers, distributors and pharmacies across the nation. In response to the growing problem of fake drugs, the U.S. Food and Drug Administration (FDA) recently issued RFID compliance guidelines. The FDA is strongly encouraging ScheduleII pharmaceutical companies to implement RFID tags, by 2007, with unique identifiers enabling them to track and trace their products throughout the supply chain.


Pfizer, in January 2006, launched a pilot program to secure the supply chain by tagging Viagra with RFID. This enables Pfizer to track and trace the product through the manufacturing process to the supplier, and even to the customer. As of April 2006 only RFID tagged bottles of Viagra are available. Pharmacists and wholesalers use the RFID tags to authenticate the drug.


Peggy Staver, Pfizer’s Director of Trade Product Integrity, presents the latest results and metrics from the first stage of Pfizer’s RFID pilot program. Join this interactive web conference to learn first hand Pfizer’s resulting metrics and analysis of the RFID program.

Take away points include: 

Sponsoring Partner

  • Combating the counterfeit drug problem
  • Implementing an RFID program in the pharmaceutical industry
  • Tracking the product through the entire supply chain
  • Developing metrics and analyzing RFID data

VPs, Heads, and Directors of:

  • Supply Chain and Logistics,
  • Security
  • Operations
  • Forecasting
  • Distribution
  • e-Supply Chain
  • Planning

Within Pharmaceutical:

  • Manufacturers
  • Wholesalers
  • Distributors
  • Retailers

Intel brings to the pharmaceutical and biotechnology industry the knowledge, experience, and commitment to connect people and information to enhance workflows and increase innovation and flexibility in both the scientific and operational departments. Though our technology platforms and experience working with industries to define and adopt standards, sharing best practices and integrating technologies and architectures , Intel can help accelerate your business from drug discovery to commercialization to supply chain management and help you create a more streamlined, efficient and profitable business. www.intel.com



Portal and B2B Marketplace profiling therapeutics biotechnology and pharmaceuticals in Canada, the U.S., the U.K., India and other emerging markets. Includes the outsourcing marketplace, jobs, news, events, company profiles, research and business resources, the BioMedical Outsourcing Report, the global venture capital database, strategic reports and more. www.canbiotech.com

and our sister site:

PharmaManufacturing's mission is to share the best practices, from all over the world, that are allowing drug manufacturing professionals to reduce production costs while improving product quality, safety and regulatory compliance. For more information on Pharma Track and Trace, a newsletter devoted to pharma's implementation of RFID and other track and trace technologies, please click here.


BioExecutive International delivers a balanced mix of executive interviews, benchmarking case studies, special reports, and expert articles that provide our 14,000 international biotech executive readers with a host of needed information and insight necessary to help build and develop the new biotech leadership.For more information please visit http://pull.xmr3.com/p/14244-BEC7/39393612/http-www.bioexecutiveintl.com.html


BioProcess International is unique - the only international publication dedicated to the development, scale-up and manufacture of biotherapeutics.  BioProcess International provides the biotherapeutic industry with monthly, peer-reviewed information necessary to successfully drive products through the biopharmaceutical, biovaccine and biodiagnostic development and manufacture process.   BioProcess International’s BPA audited circulation consists of 30,027 mid-to-upper managers working in all phases of the biotherapeutic development in the US, Europe and Canada.  Contact:  Stephanie Shaffer, sshaffer@bioprocessintl.com. http://www.bioprocessintl.com/ 

Reverse Logistics Magazine is a bi-monthly publication of the Reverse Logistics Association with a circulation of 50,000 readers worldwide.   As reverse logistics is a process that crosses all industries, readers represent the High-Tech, Retail, Medical, Pharmaceutical, Automotive, Aerospace sectors and many more.  Reverse Logistics Magazine provides the latest information on areas such as repair, customer service, parts management, EOL manufacturing, service logistics, field service, returns processing, asset management and disposal. To learn more about the Reverse Logistics Association, please visit our site at http://www.reverselogisticsassociation.org/.


Peggy Staver, Director, Trade Product Integrity, Pfizer Pharmaceutical US Trade Group


Peggy Staver is the Director, Trade Product Integrity within the Pfizer Pharmaceutical US Trade Group.  Peggy has responsibility for developing and implementing strategies to enhance patient safety and further secure the US pharmaceutical supply chain.  She is a member of Pfizer’s Product Integrity Work Group and has been involved with a number of industry initiatives assessing the value of radio frequency identification (RFID) technology in the prescription pharmaceutical market.  Peggy has been directly involved with Pfizer’s project to implement RFID technology on all U.S. Viagra packaging. In her current role, Peggy also works closely with Pfizer’s Global Security organization as it relates to investigations of suspected counterfeit or adulterated Pfizer products.  Peggy has 25 years experience in the industry in various disciplines including finance, marketing, business planning, distribution, and supply chain management.  

Copyright © 2016-2017 Honeycomb Worldwide Inc.